Author Topic: 2-methoxy-n-benzyl(5-methoxy-tryptamine)  (Read 221 times)

jon

  • Foundress Queen
  • *****
  • Posts: 1,883
2-methoxy-n-benzyl(5-methoxy-tryptamine)
« on: June 28, 2011, 09:43:48 PM »
now this is an interesting hallucinogen
if you reductively aminate 5-methoxytryptamine with 2-methoxylbenzaldehyde this would be the result of that.
what makes it so interesting is the availibility of the precursor 5-methoxyltryptamine a hydrolysis product of melatonin.
the other phenylethylamine derivatives overlay lsd quite nicely if you count the aklyl aryl ethers as double bonds in the cylic structure by reasoning of the lone pairs of the oxygen atoms and the n-benzylsubstituent overlays the diethyl amide of lsd with the methyoxyl group serving as the carboxyl group and the benzene ring serving as the two ethyl groups.
it's called a deidring model.
i was wondering if anyone had any phamacological data on this? i don't understand german all to well.
it would even more closely overlay lsd as it has the indole group and the methoxy seems to overlap that 9-10 double bond on account of it's lone pairs.
it is an lsd phamacophore.
it has 5ht2a agonist properties so it probably is more selective than lsd and possibly active in the tens of milligrams.
« Last Edit: June 28, 2011, 10:11:52 PM by jon »

antibody2

  • Subordinate Wasp
  • ***
  • Posts: 158
Re: 2-methoxy-n-benzyl(5-methoxy-tryptamine)
« Reply #1 on: June 29, 2011, 12:07:56 PM »
you might try pasting the german into babelfish to get a crude translation

http://babelfish.yahoo.com/

Tsathoggua

  • Autistic sociopath
  • Foundress Queen
  • *****
  • Posts: 662
Re: 2-methoxy-n-benzyl(5-methoxy-tryptamine)
« Reply #2 on: June 29, 2011, 01:34:17 PM »
It needs to be said, but overlay regardless, the binding mode at 5HT2a of phenethylamines is not the same as it is for tryptamines. However, it would be interesting to see the results of this in humano, nevertheless. One only finds out for sure, if its tried.

When I read this post however, I was thinking exactly the same thing about melatonin. Or for that matter, 5HTP, methylation of the phenol, and decarboxylation followed by alkylation.

Off topic, but I've often also thought it would be a good idea, simply to reduce the acetyl group to an ethyl (will LAH do this?) to give NET, then alkylate with whatever, to give for instance, 5-MeO-MET or 5-MeO-EiPT. or for that matter, the ethoxy homologs.
Nomen mihi Legio est, quia multi sumus

I'm hyperbolic, hypergolic, viral, chiral. So motherfucking twisted my laevo is on the right side.

Enkidu

  • Global Moderator
  • Foundress Queen
  • *****
  • Posts: 677
Re: 2-methoxy-n-benzyl(5-methoxy-tryptamine)
« Reply #3 on: June 30, 2011, 12:11:01 AM »
i was wondering if anyone had any phamacological data on this? i don't understand german all to well.
I heard that these were potent antagonists, but I haven't verified that.

jon

  • Foundress Queen
  • *****
  • Posts: 1,883
Re: 2-methoxy-n-benzyl(5-methoxy-tryptamine)
« Reply #4 on: June 30, 2011, 12:28:12 AM »
antagonists?
hmm sure don't look like they would fill that role.

Methansaeuretierchen

  • Larvae
  • *
  • Posts: 27
Re: 2-methoxy-n-benzyl(5-methoxy-tryptamine)
« Reply #5 on: July 01, 2011, 12:23:08 AM »
Here are tests to 5HT2A receptor affinity in rat tails. The 2-OH derivate seems to be more interesting. So salicylaldehyde has to be used. This is better as it can be made from aspirin.  3 Times the potency of pure 5HT... but hard to compare as 5HT does not break through blood/brain barrier. Still someone has to play guinea pig I think :)
Can someone translate that to something I understand?

Salicylaldehyd can be obtained from aspirin by reaction with NaOH. Then reduction for example with NaBH4+H2SO4 in ether or THF to the alcohol and then oxidation to the aldehyde.
« Last Edit: July 01, 2011, 12:38:59 AM by Methansaeuretierchen »

Enkidu

  • Global Moderator
  • Foundress Queen
  • *****
  • Posts: 677
Re: 2-methoxy-n-benzyl(5-methoxy-tryptamine)
« Reply #6 on: July 06, 2011, 04:47:05 AM »
Did you pull that from Heim's thesis? There are a couple of different signaling pathways activated by 5HT-2A. So, If they are comparing the ligands to serotonin (phospholipase C activation), the Emax values are pretty worthless.  Supposedly, you need phospholipase A2 activation for hallucinogenic effects. For anyone who wants to have a look, the thesis is here:

http://www.diss.fu-berlin.de/diss/receive/FUDISS_thesis_000000001221

Another one is (i'm feeling too lazy to post it right now):

Maria Elena Silva, Ralf Heim, Andrea Strasser, Sigurd Elz, Stefan Dove
"Theoretical studies on the interaction of partial agonists with the 5-HT2A receptor"
Journal of Computer-Aided Molecular Design 2011, 25(1), pp.51-66
DOI: 10.1007/s10822-010-9400-2

jon

  • Foundress Queen
  • *****
  • Posts: 1,883
Re: 2-methoxy-n-benzyl(5-methoxy-tryptamine)
« Reply #7 on: July 06, 2011, 07:53:29 AM »
yeah it was heim's thesis i got to get off my lazy chair and crack that german to see what this is all about.

dmtubbler

  • Larvae
  • *
  • Posts: 4
Re: 2-methoxy-n-benzyl(5-methoxy-tryptamine)
« Reply #8 on: October 17, 2011, 11:00:04 PM »
So very cool.   Wonder if it will bee tried in a human?  Would one of the more knowledgeable members be able to make a guess as to what it would be like? I would love to know.

metamorphin

  • Larvae
  • *
  • Posts: 13
Re: 2-methoxy-n-benzyl(5-methoxy-tryptamine)
« Reply #9 on: October 17, 2011, 11:10:53 PM »
I can translate that thing for you tomorrow or the day after tomorrow , I also found it to be quite interesting.


Edit: Nevermind that, I didn´t think it was so much stuff, I can translate bits from the synthesis part though, if you are interested in something particular.

Synthesis and pharmacology of potent 5-HT2A -receptor agonists with N-2-methoxybenzyl- partial structure
- development of a new structure-activity-concept

Serotonin-2A(5-HT2A)-receptors play a central role in causing mental illnesses such as depression and shizophrenia. Additionally, the 5-HT2A-receptor subtype seems to have an important influence on modification of perception and emotion. Subtype-selective substances  are  important experimental tools in medical-pharmacoligical basic research for examination and  clarification of complex physiological and pathophysiological processes with involvement of the neurotransmitter serotonin(5-HT). 

Based on an unexpected partial agonist  effect of a molecular fragment of  the classic 5-HT2A-receptor agonist Ketanserin, a new structure-activity-concept for   5-HT2A-receptor agonists for the substance class of  3-(2-aminoethyl)-2,4(1H,3H)quinazolindiones  could be developed in this dissertation. This structure-activity-concept, according to which a N-2-methoxy- or N-2-hydroxybenzyl-function, respectively, gives 5-HT2A-receptor agonists with primary amine structure an exceptionally high activity, could satisfactorily be transferred to other substance classes like tryptamines and phenethylamines. 

The key step of the synthesis of N-substituted amines of the 3-(2-aminoethyl)-2,4-quinazolindion type is the nucleophilic ring opening of the tricycle 2,3-dihydro-5-oxo-5H-oxazolo-[2,3-b]-quinazolin (95) with several primary amines. The most potent representative of this class is the o-methoxybenzyl-derivative 169 (pEC50 = 6.58, Emax = 49 %), which exhibits more than a 250-fold increase  in partial agonist activity when compared to the basic structure  93 with primary amine function.

The synthesis of the N-benzylated  2-(1H-Indol-3-yl)ethylamin derivatives succeeded from tryptamine and 5-methoxytryptamine through indirect reductive alkylation. The sysnthesis of the N-2-methoxybenzyl-substituted phenethylamines of the DOB- and DOI-type, respectively, proceeded from 2,5-dimethoxybenzaldehyde with the sequenz: Henry-reaction, following reduction of the nitrostyrenes and final reductive alkylation of the primary amines.
An alternative synthesis route makes the direct introduction of a Cbz-protected aminoethyl-sidechain in an one-pot-reaction via hydroboration/Suzuki-coupling possible.

The most potent substances in the phenethylamine class are the compounds which are brominated/iodinated in the 4-position 230, 231 / 235, 236, which produced activity in in-vitro models of rat vessels even in nanomolecular concentrations. With pEC50-values between 9.58 (0.26 nmol × L-1) and 10.13 (74 pmol × L-1) the strength of activity of these partial agonists is 384- to 1350-fold higher than that of the reference agonist serotonin and almost 106-times higher than that of the basic structure 93. With the synthesis of the equally high potent tetrahydrobenzofurans 270 and 271 (pEC50 = 9.87 resp. 10.15) – rigidisated analogs of the 2,5-dimethoxyphenylethylamies  230 and 231 – important clues for the active binding conformation of these substances could be found.

For examining the stereoselectivity of the  5-HT2A-receptor binding site both enantiomeres of both the chiral Chinazolindions 298 and the chiral 2,5-Dimethoxyphenylethylamines 304 and 305 were synthesized in high optical purity(ee>99%). The synthesis of the necessary chiral key building block 1-(2-methoxyphenyl)ethylamine (288) suceeded through a highly diastereoselectiv reductive amination (d.r. = 97 : 3), which provides both enantiomers in excellent enantiomeric purity (ee > 99 %).


Additionally, a second synthesis route using enzyme-catalyzed kinetic racemical fission of the (±)-N-[1-(2-methoxyphenyl)ethyl]oxalic acid octylester (291) with immobilised Lipase B from the species Candida antarctica was pursued.
« Last Edit: October 18, 2011, 02:31:25 PM by metamorphin »